Pfizer的股票看到主要投资者在问题1金融结果好坏参半的情况下对股权进行调整。 Pfizer's stock sees stake adjustments by major investors amid mixed Q1 financial results.

机构投资者正在调整对辉瑞公司的股权,Apricus财富公司持股量增加了20 406股,现在拥有110 791股,价值280万美元。 Institutional investors are adjusting their stakes in Pfizer Inc., with Apricus Wealth increasing holdings by 20,406 shares, now owning 110,791 shares valued at $2.8 million. 同时,Mogy Joel R Investment adviseration Inc. 将股份减少了11.1%,而Union Bancaire Privee UBPSA将其股份增加了12.1%。 Meanwhile, Mogy Joel R Investment Counsel Inc. reduced its stake by 11.1%, and Union Bancaire Privee UBP SA increased its holdings by 12.1%. Pfizer的第一季度每股收入比分析师的预期高出0.92美元,尽管收入略低于预测的137.2亿美元。 Pfizer's first-quarter earnings per share beat analyst expectations at $0.92, though revenue was slightly below forecasts at $13.72 billion. 该公司提供一系列药品和疫苗,包括用于心血管和偏头痛治疗的药品和疫苗。 The company offers a range of medicines and vaccines, including those for cardiovascular and migraine treatments.